Head-to-head · Cost-Efficiency Index
Heva Health vs LifeMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Heva Health
Shoppers who want a concierge lab-panel-plus-GLP-1 bundle and can confirm their state isn't one of tirzepatide's five exclusions.
Visit Heva HealthLifeMD
Cost-first shoppers who want insured shoppers chasing a low branded-GLP-1 copay, who understand the program fee and medication cost are billed separately.
Visit LifeMDThe verdict
Heva Health and LifeMD tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Heva Health (ranked #249, a hair above #252) — Shoppers who want a concierge lab-panel-plus-GLP-1 bundle and can confirm their state isn't one of tirzepatide's five exclusions. But LifeMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Heva Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Heva Health | LifeMD |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | $150/mo (starting dose, compounded) | $298/mo (brand Wegovy) |
| Tirzepatide / mo | $339/mo (compounded) | $498/mo (brand Zepbound, plus a separate fee) |
| Semaglutide / yr (modeled) | $1,800 | $3,576 |
| Tirzepatide / yr (modeled) | $4,068 | $5,976 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #249 | #252 |
Heva Health
60/100Where the value is
- Tirzepatide pricing is broken out into a clear, labeled ladder ($339/mo month-to-month down to $299/mo on a 6-month plan) rather than a single vague 'starting at' figure
- Explicitly discloses a real state-level restriction for tirzepatide (unavailable in Alaska, Arkansas, Indiana, Minnesota, South Carolina) instead of a vague coverage claim
- Named, credentialed care team (Dr. Caroline Tade NMD, Kasey Horrell PA-C, Dr. Daniel Hall DNP/NP-C, Kelly Moore FNP)
The tradeoffs
- The $149.99/month 'Weight Loss Program' figure is never explicitly confirmed as the semaglutide-specific price on the pages checked — it may be a generic teaser rather than a labeled per-drug rate
- Tirzepatide's '3-Month Program' is listed at the identical $339/month as the month-to-month rate despite being advertised as '15% savings vs month-to-month' — a page inconsistency worth flagging before treating either figure as final
LifeMD
60/100Where the value is
- LegitScript certified, publicly traded (NASDAQ: LFMD), with its own affiliated pharmacy processing up to 5,000 scripts/day
- Sells FDA-approved branded Wegovy and Zepbound rather than compounded copies, in both pill and pen formats for Wegovy
- Insured patients may pay as little as $0-25 per fill via manufacturer savings-card integration
The tradeoffs
- The program fee and the medication cost are billed completely separately, and both are labeled with overlapping $149 figures — a shopper reading either number alone will underestimate the real monthly cost by roughly half
- The advertised '$39 first month' is a one-time discount on the program fee only; the standing program fee is $149/month starting month two
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.